Antitumor Effects of Resveratrol Opposing Mechanisms of Helicobacter pylori in Gastric Cancer
- Daniela Trautmann,
- Francesca Suazo,
- Keila Torres(autore corrispondente),
- Layla Simón(autore corrispondente)
- Universidad Finis Terrae,
- Pontificia Universidad Católica de Chile,
- ,
- ,
- ,
Prodotto della ricerca:
Contribution to journal
Review article
Research
Peer reviewOpen Access
Publication Information
Tipo di output
Prodotto della ricerca:
Contribution to journal
Review article
Research
Peer reviewLingua originale
EnglishNumero dell’articolo
2141Rivista (volume, numero edizione)
Nutrients (Volume 16, Edizione 13)Attività cardine della pubblicazione
- Published - 01/07/2024
Stato pubblicazione
Published - 01/07/2024
ID pubblicazione
- Scopus: 85198416544
- PubMed: 38999888
Abstract
<p>Gastric cancer is an aggressive and multifactorial disease. Helicobacter pylori (H. pylori) is identified as a significant etiological factor in gastric cancer. Although only a fraction of patients infected with H. pylori progresses to gastric cancer, bacterial infection is critical in the pathology and development of this malignancy. The pathogenic mechanisms of this bacterium involve the disruption of the gastric epithelial barrier and the induction of chronic inflammation, oxidative stress, angiogenesis and metastasis. Adherence molecules, virulence (CagA and VacA) and colonization (urease) factors are important in its pathogenicity. On the other hand, resveratrol is a natural polyphenol with anti-inflammatory and antioxidant properties. Resveratrol also inhibits cancer cell proliferation and angiogenesis, suggesting a role as a potential therapeutic agent against cancer. This review explores resveratrol as an alternative cancer treatment, particularly against H. pylori-induced gastric cancer, due to its ability to mitigate the pathogenic effects induced by bacterial infection. Resveratrol has shown efficacy in reducing the proliferation of gastric cancer cells in vitro and in vivo. Moreover, the synergistic effects of resveratrol with chemotherapy and radiotherapy underline its therapeutic potential. However, further research is needed to fully describe its efficacy and safety in treating gastric cancer.</p>
Access to documents
Publication metrics
Metriche
SciVal
FWCI
0.83
PlumX, si apre in una nuova scheda
Captures
21
Usage
395
Mentions
1
Citation count
18
